Bookmarks
Using genetics and healthcare data to understand disease and create innovative medicines
Safe People
Organisation name
Novartis
Organisation sector
Commercial
Applicant name(s)
Jonathan Chung
Funders/ Sponsors
Safe Projects
Project ID
OFHS250141
Lay summary
The aim of this study is to improve our understanding of how different diseases develop and progress. By doing so, we hope to find new and safer treatment options. Additionally, the study seeks to discover better methods for early detection and ongoing monitoring of diseases, as well as to identify which groups of patients are most likely to benefit from specific treatments across a wide range of health conditions. Novartis wants to help people live longer and healthier lives by creating new medicines for diseases that don’t have good treatments yet. To do this, we’ll use data from Our Future Health (OFH), the UK’s largest health research program. It includes genetic and healthcare information from a wide range of people. By studying this data, we aim to understand what causes complex diseases, how they develop, and why they affect people differently. This will help us find new drug targets, group patients more effectively, and predict possible side effects. These insights can also lead to better tools for early diagnosis and new uses for existing medicines. In the end, this research will support safer, more precise, and innovative treatments for many health conditions.
Public benefit statement
This research uses genetic and medical data to understand how diseases begin and develop. With this knowledge, we aim to create new medicines and better treatments. By including a large, diverse group of people, we can make sure our discoveries help many communities, reduce health gaps, and bring medical advances to those who need them most.
Request category type
Public Health Research
Other approval committees
Project start date
30/04/2026
Latest approval date
21/02/2026
Safe Data
Dataset(s) name
Safe Setting
Access type
TRE